APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Olaparib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchOlaparib Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Olaparib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib Tablets Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Olaparib Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Olaparib Tablets include CSPC Ouyi Pharmaceutical, Qilu Pharmaceutical, Merck, Kelun Pharmaceutical, Sino Therapeutics, Jiangsu Litaier Pharmaceuticals, Huadong Medicin, Natco Pharma and Everest Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Olaparib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Olaparib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Olaparib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Olaparib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Olaparib Tablets Segment by Company

CSPC Ouyi Pharmaceutical

Qilu Pharmaceutical

Merck

Kelun Pharmaceutical

Sino Therapeutics

Jiangsu Litaier Pharmaceuticals

Huadong Medicin

Natco Pharma

Everest Pharmaceuticals

BDR Pharmaceuticals

AstraZeneca

Olaparib Tablets Segment by Type

100mg per Tablet

500mg per Tablet

Olaparib Tablets Segment by Application

Ovarian Cancer

Breast Cancer

Metastatic Prostate Cancer

Metastatic Pancreatic Cancer

Olaparib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Olaparib Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olaparib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Olaparib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Olaparib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Olaparib Tablets Industry Trends Table 2. Olaparib Tablets Industry Drivers Table 3. Olaparib Tablets Industry Opportunities and Challenges Table 4. Olaparib Tablets Industry Restraints Table 5. Global Olaparib Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Olaparib Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Olaparib Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Olaparib Tablets Sales Market Share by Manufacturers Table 9. Global Olaparib Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Olaparib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Olaparib Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Olaparib Tablets Manufacturers, Product Type & Application Table 13. Global Olaparib Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Olaparib Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg per Tablet Table 17. Major Manufacturers of 500mg per Tablet Table 18. Global Olaparib Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Olaparib Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Olaparib Tablets Sales Market Share by Type (2021-2026) Table 22. Global Olaparib Tablets Sales Market Share by Type (2027-2032) Table 23. Global Olaparib Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Olaparib Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Olaparib Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Olaparib Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Olaparib Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Ovarian Cancer Table 29. Major Manufacturers of Breast Cancer Table 30. Major Manufacturers of Metastatic Prostate Cancer Table 31. Major Manufacturers of Metastatic Pancreatic Cancer Table 32. Global Olaparib Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 34. Global Olaparib Tablets Sales by Application (2027-2032) & (K Units) Table 35. Global Olaparib Tablets Sales Market Share by Application (2021-2026) Table 36. Global Olaparib Tablets Sales Market Share by Application (2027-2032) Table 37. Global Olaparib Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Olaparib Tablets Revenue by Application (2021-2026) & (K Units) Table 39. Global Olaparib Tablets Revenue by Application (2027-2032) & (K Units) Table 40. Global Olaparib Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Olaparib Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Olaparib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Olaparib Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Olaparib Tablets Sales Market Share by Region (2021-2026) Table 45. Global Olaparib Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Olaparib Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 49. North America Olaparib Tablets Sales by Country (2027-2032) & (K Units) Table 50. Europe Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 52. Europe Olaparib Tablets Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Olaparib Tablets Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Olaparib Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Olaparib Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Olaparib Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Olaparib Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Olaparib Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Olaparib Tablets Revenue Market Share by Region (2027-2032) Table 64. CSPC Ouyi Pharmaceutical Company Information Table 65. CSPC Ouyi Pharmaceutical Business Overview Table 66. CSPC Ouyi Pharmaceutical Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CSPC Ouyi Pharmaceutical Olaparib Tablets Product Portfolio Table 68. CSPC Ouyi Pharmaceutical Recent Development Table 69. Qilu Pharmaceutical Company Information Table 70. Qilu Pharmaceutical Business Overview Table 71. Qilu Pharmaceutical Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Qilu Pharmaceutical Olaparib Tablets Product Portfolio Table 73. Qilu Pharmaceutical Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Olaparib Tablets Product Portfolio Table 78. Merck Recent Development Table 79. Kelun Pharmaceutical Company Information Table 80. Kelun Pharmaceutical Business Overview Table 81. Kelun Pharmaceutical Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Kelun Pharmaceutical Olaparib Tablets Product Portfolio Table 83. Kelun Pharmaceutical Recent Development Table 84. Sino Therapeutics Company Information Table 85. Sino Therapeutics Business Overview Table 86. Sino Therapeutics Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sino Therapeutics Olaparib Tablets Product Portfolio Table 88. Sino Therapeutics Recent Development Table 89. Jiangsu Litaier Pharmaceuticals Company Information Table 90. Jiangsu Litaier Pharmaceuticals Business Overview Table 91. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product Portfolio Table 93. Jiangsu Litaier Pharmaceuticals Recent Development Table 94. Huadong Medicin Company Information Table 95. Huadong Medicin Business Overview Table 96. Huadong Medicin Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Huadong Medicin Olaparib Tablets Product Portfolio Table 98. Huadong Medicin Recent Development Table 99. Natco Pharma Company Information Table 100. Natco Pharma Business Overview Table 101. Natco Pharma Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Natco Pharma Olaparib Tablets Product Portfolio Table 103. Natco Pharma Recent Development Table 104. Everest Pharmaceuticals Company Information Table 105. Everest Pharmaceuticals Business Overview Table 106. Everest Pharmaceuticals Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Everest Pharmaceuticals Olaparib Tablets Product Portfolio Table 108. Everest Pharmaceuticals Recent Development Table 109. BDR Pharmaceuticals Company Information Table 110. BDR Pharmaceuticals Business Overview Table 111. BDR Pharmaceuticals Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. BDR Pharmaceuticals Olaparib Tablets Product Portfolio Table 113. BDR Pharmaceuticals Recent Development Table 114. AstraZeneca Company Information Table 115. AstraZeneca Business Overview Table 116. AstraZeneca Olaparib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. AstraZeneca Olaparib Tablets Product Portfolio Table 118. AstraZeneca Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Olaparib Tablets Distributors List Table 122. Olaparib Tablets Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Olaparib Tablets Product Image Figure 2. Global Olaparib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Olaparib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Olaparib Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Olaparib Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg per Tablet Image Figure 9. 500mg per Tablet Image Figure 10. Global Olaparib Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Olaparib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Olaparib Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Olaparib Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Olaparib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Olaparib Tablets Revenue Market Share by Type (2021-2032) Figure 16. Ovarian Cancer Image Figure 17. Breast Cancer Image Figure 18. Metastatic Prostate Cancer Image Figure 19. Metastatic Pancreatic Cancer Image Figure 20. Global Olaparib Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Olaparib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Olaparib Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Olaparib Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Olaparib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Olaparib Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Olaparib Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Olaparib Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Olaparib Tablets Sales Market Share by Country (2021-2032) Figure 40. China Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Olaparib Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Olaparib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Olaparib Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Olaparib Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Olaparib Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Olaparib Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Olaparib Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Olaparib Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Olaparib Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Olaparib Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 500mg per Tablet
Applications
  • Ovarian Cancer
  • Breast Cancer
  • Metastatic Prostate Cancer
  • Metastatic Pancreatic Cancer
Companies covered
  • CSPC Ouyi Pharmaceutical
  • Qilu Pharmaceutical
  • Merck
  • Kelun Pharmaceutical
  • Sino Therapeutics
  • Jiangsu Litaier Pharmaceuticals
  • Huadong Medicin
  • Natco Pharma
  • Everest Pharmaceuticals
  • BDR Pharmaceuticals
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Olaparib Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Olaparib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Olaparib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Olaparib Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Olaparib Tablets Market Dynamics
  1. 2.1 Olaparib Tablets Industry Trends
  2. 2.2 Olaparib Tablets Industry Drivers
  3. 2.3 Olaparib Tablets Industry Opportunities and Challenges
  4. 2.4 Olaparib Tablets Industry Restraints
3 Olaparib Tablets Market by Manufacturers
  1. 3.1 Global Olaparib Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Olaparib Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Olaparib Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Olaparib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olaparib Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Olaparib Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Olaparib Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olaparib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olaparib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olaparib Tablets Tier 1, Tier 2, and Tier 3
4 Olaparib Tablets Market by Type
  1. 4.1 Olaparib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 500mg per Tablet
  4. 4.2 Global Olaparib Tablets Sales by Type
  5. 4.2.1 Global Olaparib Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Olaparib Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Olaparib Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Olaparib Tablets Revenue by Type
  9. 4.3.1 Global Olaparib Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Olaparib Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Olaparib Tablets Revenue Market Share by Type (2021-2032)
5 Olaparib Tablets Market by Application
  1. 5.1 Olaparib Tablets Application Introduction
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Metastatic Prostate Cancer
  5. 5.1.4 Metastatic Pancreatic Cancer
  6. 5.2 Global Olaparib Tablets Sales by Application
  7. 5.2.1 Global Olaparib Tablets Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Olaparib Tablets Sales by Application (2021-2032)
  9. 5.2.3 Global Olaparib Tablets Sales Market Share by Application (2021-2032)
  10. 5.3 Global Olaparib Tablets Revenue by Application
  11. 5.3.1 Global Olaparib Tablets Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Olaparib Tablets Revenue by Application (2021-2032)
  13. 5.3.3 Global Olaparib Tablets Revenue Market Share by Application (2021-2032)
6 Global Olaparib Tablets Sales by Region
  1. 6.1 Global Olaparib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Olaparib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Olaparib Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Olaparib Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Olaparib Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Olaparib Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Olaparib Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Olaparib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Olaparib Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Olaparib Tablets Revenue by Region
  1. 7.1 Global Olaparib Tablets Revenue by Region
  2. 7.1.1 Global Olaparib Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Olaparib Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Olaparib Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Olaparib Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Olaparib Tablets Revenue (2021-2032)
  8. 7.2.2 North America Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Olaparib Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Olaparib Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Olaparib Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Olaparib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Ouyi Pharmaceutical
  2. 8.1.1 CSPC Ouyi Pharmaceutical Company Information
  3. 8.1.2 CSPC Ouyi Pharmaceutical Business Overview
  4. 8.1.3 CSPC Ouyi Pharmaceutical Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Ouyi Pharmaceutical Olaparib Tablets Product Portfolio
  6. 8.1.5 CSPC Ouyi Pharmaceutical Recent Developments
  7. 8.2 Qilu Pharmaceutical
  8. 8.2.1 Qilu Pharmaceutical Company Information
  9. 8.2.2 Qilu Pharmaceutical Business Overview
  10. 8.2.3 Qilu Pharmaceutical Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharmaceutical Olaparib Tablets Product Portfolio
  12. 8.2.5 Qilu Pharmaceutical Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Olaparib Tablets Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Kelun Pharmaceutical
  20. 8.4.1 Kelun Pharmaceutical Company Information
  21. 8.4.2 Kelun Pharmaceutical Business Overview
  22. 8.4.3 Kelun Pharmaceutical Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kelun Pharmaceutical Olaparib Tablets Product Portfolio
  24. 8.4.5 Kelun Pharmaceutical Recent Developments
  25. 8.5 Sino Therapeutics
  26. 8.5.1 Sino Therapeutics Company Information
  27. 8.5.2 Sino Therapeutics Business Overview
  28. 8.5.3 Sino Therapeutics Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sino Therapeutics Olaparib Tablets Product Portfolio
  30. 8.5.5 Sino Therapeutics Recent Developments
  31. 8.6 Jiangsu Litaier Pharmaceuticals
  32. 8.6.1 Jiangsu Litaier Pharmaceuticals Company Information
  33. 8.6.2 Jiangsu Litaier Pharmaceuticals Business Overview
  34. 8.6.3 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product Portfolio
  36. 8.6.5 Jiangsu Litaier Pharmaceuticals Recent Developments
  37. 8.7 Huadong Medicin
  38. 8.7.1 Huadong Medicin Company Information
  39. 8.7.2 Huadong Medicin Business Overview
  40. 8.7.3 Huadong Medicin Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huadong Medicin Olaparib Tablets Product Portfolio
  42. 8.7.5 Huadong Medicin Recent Developments
  43. 8.8 Natco Pharma
  44. 8.8.1 Natco Pharma Company Information
  45. 8.8.2 Natco Pharma Business Overview
  46. 8.8.3 Natco Pharma Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Olaparib Tablets Product Portfolio
  48. 8.8.5 Natco Pharma Recent Developments
  49. 8.9 Everest Pharmaceuticals
  50. 8.9.1 Everest Pharmaceuticals Company Information
  51. 8.9.2 Everest Pharmaceuticals Business Overview
  52. 8.9.3 Everest Pharmaceuticals Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Everest Pharmaceuticals Olaparib Tablets Product Portfolio
  54. 8.9.5 Everest Pharmaceuticals Recent Developments
  55. 8.10 BDR Pharmaceuticals
  56. 8.10.1 BDR Pharmaceuticals Company Information
  57. 8.10.2 BDR Pharmaceuticals Business Overview
  58. 8.10.3 BDR Pharmaceuticals Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BDR Pharmaceuticals Olaparib Tablets Product Portfolio
  60. 8.10.5 BDR Pharmaceuticals Recent Developments
  61. 8.11 AstraZeneca
  62. 8.11.1 AstraZeneca Company Information
  63. 8.11.2 AstraZeneca Business Overview
  64. 8.11.3 AstraZeneca Olaparib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AstraZeneca Olaparib Tablets Product Portfolio
  66. 8.11.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Olaparib Tablets Value Chain Analysis
  2. 9.1.1 Olaparib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Olaparib Tablets Production Mode & Process
  6. 9.2 Olaparib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Olaparib Tablets Distributors
  9. 9.2.3 Olaparib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst